Your session is about to expire
← Back to Search
Behavioural Intervention
Text-Based Smoking Cessation Program for Quitting Smoking
N/A
Recruiting
Led By Irene Tami-Maury, DMD,MSc,DrPH-NHSN
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke greater than or equal to 5 cigarettes a day
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of month 6
Awards & highlights
Study Summary
This trial tests an SGM-specific program to help sexual/gender minorities quit smoking. It checks how effective & acceptable it is.
Who is the study for?
This trial is for LGBTQ+ individuals who want to quit smoking, smoke at least 5 cigarettes daily, and have smoked over 100 in their lifetime. They must live in Texas, have a cell phone with unlimited texting, and test positive for nicotine use. Excluded are non-English speakers, those on cessation meds or prepaid phones, pregnant/breastfeeding persons, and people with certain medical conditions.Check my eligibility
What is being tested?
The study is evaluating SmokefreeSGM—a tailored text messaging program designed to help sexual and gender minority groups quit smoking—against the standard SmokefreeTXT program. Participants will receive supportive texts aimed at aiding smoking cessation.See study design
What are the potential side effects?
Since this trial involves text-based interventions without medications or invasive procedures, there are no direct physical side effects expected from participation. However, participants may experience stress or anxiety related to quitting smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have smoked more than 100 cigarettes in my life and currently smoke 5 or more daily.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of month 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of month 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility as assessed by number of participants recruited for the study
Feasibility as assessed by number of participants that completed month 1 visit
Feasibility as assessed by number of participants that completed month 3 visit
+2 moreSecondary outcome measures
Acceptability as assessed by qualitative interviews
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SmokefreeSGMExperimental Treatment1 Intervention
Group II: SmokefreeTXTActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SmokefreeSGM
2022
N/A
~20
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
909 Previous Clinical Trials
323,661 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,703 Previous Clinical Trials
40,931,720 Total Patients Enrolled
Irene Tami-Maury, DMD,MSc,DrPH-NHSNPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cell phone number is incorrect or registered to another person.I lack the necessary equipment for telehealth and cannot meet in person.I am not pregnant or breastfeeding.I am currently using medication to help me stop smoking.You agree to stop smoking within the next 15 days.You identify as a member of the LGBTQ+ community.I have smoked more than 100 cigarettes in my life and currently smoke 5 or more daily.I have a cell phone with unlimited texting.
Research Study Groups:
This trial has the following groups:- Group 1: SmokefreeSGM
- Group 2: SmokefreeTXT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an opportunity to join this clinical research endeavor currently?
"According to the particulars on clinicaltrials.gov, recruitment for this trail is in progress with an initial posting date of November 10th 2022 and a most recent update dated December 1st 2022."
Answered by AI
How many subjects are being examined in this investigation?
"Affirmative. According to details posted on clinicaltrials.gov, this medical trial is presently recruiting patients and was initially published on November 10th 2022. 80 individuals have been requested from the sole participating site with updates being provided as recently as December 1st 2022."
Answered by AI
Share this study with friends
Copy Link
Messenger